Johnson & Johnson (JNJ) Financials
JNJ Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2026 | ? | ? |
| June 30, 2026 | 201.1 billion | 116.1 billion |
| March 31, 2026 | 200.9 billion | 119.7 billion |
| Dec. 31, 2025 | 199.2 billion | 117.7 billion |
JNJ Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2026 | ? | ? |
| June 30, 2026 | 3.4 billion | 458.0 million |
| March 31, 2026 | 1.5 billion | 300.0 million |
| Dec. 31, 2025 | 5.5 billion | 309.0 million |
JNJ Net Income
| Date | Net Income |
|---|---|
| Sept. 30, 2026 | ? |
| June 30, 2026 | 5.5 billion |
| March 31, 2026 | 5.2 billion |
| Dec. 31, 2025 | 5.1 billion |
JNJ Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2026 | - | - | - |
| June 30, 2026 | 20.8 billion | 37.3 billion | - |
| March 31, 2026 | 22.1 billion | 37.5 billion | - |
| Dec. 31, 2025 | 20.1 billion | 39.4 billion | - |
JNJ Shares Outstanding
JNJ Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2026 | - | 4.7 billion | 6.3 billion | - |
| June 30, 2026 | 1.3 billion | 3.7 billion | 6.4 billion | - |
| March 31, 2026 | 1.0 billion | 3.5 billion | 6.0 billion | - |
| Dec. 31, 2025 | 1.8 billion | 4.3 billion | 6.8 billion | - |
JNJ Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2026 | 25.4 billion | 6.9 billion |
| June 30, 2026 | 25.3 billion | 8.1 billion |
| March 31, 2026 | 24.1 billion | 8.1 billion |
| Dec. 31, 2025 | 24.6 billion | 8.0 billion |
JNJ Revenue by Segment
JNJ
List: Champions
Price: $271.22
Dividend Yield: 0.51%
Forward Dividend Yield: 1.98%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 6.59 USD
P/E Ratio: 38.78
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 615.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 4.92%
DGR5: 5.25%
DGR10: 5.71%
DGR20: 7.24%